Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AVASTIN /01555201 Cause Malignant neoplasm progression? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with AVASTIN /01555201. This represents 22.0% of all adverse event reports for AVASTIN /01555201.

9
Reports of Malignant neoplasm progression with AVASTIN /01555201
22.0%
of all AVASTIN /01555201 reports
4
Deaths
2
Hospitalizations

How Dangerous Is Malignant neoplasm progression From AVASTIN /01555201?

Of the 9 reports, 4 (44.4%) resulted in death, 2 (22.2%) required hospitalization.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AVASTIN /01555201. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does AVASTIN /01555201 Cause?

Diarrhoea (8) Death (6) Fatigue (6) Nausea (5) Rash (5)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Related Pages

AVASTIN /01555201 Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression AVASTIN /01555201 Demographics